Will the real "hepatobiliary cystadenocarcinoma" please stand up? True malignancy is exceedingly rare in cystic liver lesions; implications for pathologic evaluation and pre-operative decision making
![Thumbnail](/xmlui/bitstream/handle/20.500.12511/6765/Saka-Burcu--2021.pdf.jpg?sequence=4&isAllowed=y)
Göster/ Aç
Erişim
info:eu-repo/semantics/openAccessTarih
2021Yazar
Armutlu, AyşeQuigley, Brian
Choi, Hegyong
Baştürk, Olca
Akkaş, Gizem
Pehlivanoğlu, Burçin
Memiş, Bahar
Jang, Keetaek
Erkan, Mert
Erkan, Burcu
Balcı, Serdar
Saka, Burcu
Bağcı Çulçi, Pelin
Farris, Alton Brad
Kooby, David
Martin, Diego
Kalb, Bobby
Maithel, Shishir
Sarmiento, Juan
Reid, Michelle
Adsay, Nazmi Volkan
Üst veri
Tüm öğe kaydını gösterKünye
Armutlu, A., Quigley, B., Choi, H., Baştürk, O., Akkaş, G., Pehlivanoğlu, B. ... Adsay, N. V. (2021). Will the real "hepatobiliary cystadenocarcinoma" please stand up? True malignancy is exceedingly rare in cystic liver lesions; implications for pathologic evaluation and pre-operative decision making. Laboratory Investigation içinde (959-961. ss.).Özet
Background: Concern for hepatic cysts being “hepatobiliary cystadenocarcinoma” along with the allegedly high frequency of its occurrence in the literature (up to 30% of the hepatic cysts) remains a major driver for the management of cystic lesions in this organ.
WoS Q Kategorisi
Q1Kaynak
Laboratory InvestigationCilt
101Sayı
Supplement: 1Koleksiyonlar
- Bildiri Koleksiyonu [516]
- WoS İndeksli Yayınlar Koleksiyonu [6677]